Disease Information & Support


The Word:


Relapsed or Refractory ALL

Some patients still have leukemia cells in their bone marrow after ALL treatment. This is called refractory leukemia. Some patients have a return of ALL cells in the marrow and a decrease in normal blood cells after remission. This is called a relapse.

The following drug is FDA approved to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). For more information, click on the link.

Additional treatment options for refractory ALL include:

If you have relapsed ALL, you may be given more chemotherapy with the same or different drugs used previously during your treatment. Some patients may also have a stem cell transplantation or be a part of a clinical trial.

Your therapy options depend on two factors:

  • your remission's duration
  • the cytogenetic findings that reveal abnormal changes to the structure of chromosomes in your leukemia cells
last updated on Monday, December 08, 2014

Get Information
& Support

Contact an Information Specialist.

Newly Diagnosed?